RBM12B-AS1

Across TCGA pan-cancer cohorts, RBM12B-AS1 RNA is linked to patient survival in 21 of 34 cancer types, making it the most broadly survival-associated RBM12B-AS1 data layer.

The strongest signal is observed in uterine carcinosarcoma (UCS), where higher RBM12B-AS1 RNA is associated with better overall survival. In most high-consensus cancer types, elevated RBM12B-AS1 expression acts as an unfavorable survival marker, although some lineages such as UCS and READ show a favorable association.

UCS, THCA, and UVM are the cancer types where RBM12B-AS1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCS	OS	Median	III,IV	0.574	0.178	.002	74	view →
THCA	DFS	Median	III,IV	0.507	0.839	.001	69	view →
UVM	DFS	Quartile	III,IV	0.163	0.903	<.001	54	view →
ACC	OS	Median	All	0.289	0.863	<.001	42	view →
COAD	DFS	Median	All	0.600	0.766	.001	40	view →
KIRP	DFS	Tertile	All	0.523	0.807	<.001	35	view →
READ	OS	Median	III,IV	1.000	0.373	.007	28	view →
SARC	DFS	Median	All	0.456	0.720	<.001	28	view →
BRCA	DFS	Tertile	III,IV	0.924	0.783	.002	27	view →
KICH	OS	Quartile	III,IV	0.178	1.000	.017	26	view →
LGG	OS	Quartile	All	0.317	0.725	<.001	24	view →
BLCA	DFS	Median	IV	0.290	0.606	.008	13	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 21 lineages.

RBM12B-AS1–UCS (OS)

Open the UCS breakdown →